⌘K
t
Faron Pharmaceuticals Ltd. announced on 11 February 2025 the immediate appointment of Cairn Financial Advisers LLP as its new broker, replacing Peel Hunt LLP. Cairn Financial Advisers LLP will also continue to act as the Company's Nominated Adviser.
| Date | 11 Feb 2025 |
| Time | 07:30:00 |
| Category | Corporate updates |
| ID | 6628W |
Faron Pharmaceuticals Ltd.
("Faron" or "the Company")
Change of Broker
Company announcement, 11 February 2025
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces the appointment of Cairn Financial Advisers LLP as broker to the Company with immediate effect in place of Peel Hunt LLP. Cairn Financial Advisers LLP will also continue to act as the Company's Nominated Adviser.
For more information please contact:
ICR Healthcare
Mary-Jane Elliott, David Daley, Lindsey Neville
Phone: +44 (0)20 3709 5700
E-mail: faron@icrhealthcare.com
Cairn Financial Advisers LLP, Nominated Adviser and Broker
Sandy Jamieson, Jo Turner
Phone: +44 (0) 207 213 0880
Sisu Partners Oy, Certified Adviser on Nasdaq First North
Juha Karttunen
Phone: +358 (0)40 555 4727
Jukka Järvelä
Phone: +358 (0)50 553 8990